Ikena Oncology weighs ‘strategic options’ as it drops cancer asset, trims headcount to save cash
Ikena Oncology has hit another speed bump as it ends work on a Phase 1 oncology candidate and plans to slash its workforce by more …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
